Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 32426-57-6
2. Lysergide D-tartrate
3. D-lsd 25 Bitartrate
4. 7wnp51ka7m
5. Lysergide Tartrate
6. Ergoline-8-beta-carboxamide, 9,10-didehydro-n,n-diethyl-6-methyl-, Tartrate (1:1), D-
7. (6ar,9r)-n,n-diethyl-7-methyl-6,6a,8,9-tetrahydro-4h-indolo[4,3-fg]quinoline-9-carboxamide;(2s,3s)-2,3-dihydroxybutanedioic Acid
8. (6ar,9r)-n,n-diethyl-7-methyl-6,6a,8,9-tetrahydro-4h-indolo[4,3-fg]quinoline-9-carboxamide;2,3-dihydroxybutanedioic Acid
9. D-9,10-didehydro-n,n-diethyl-6-methylergoline-8-beta-carboxamide Tartrate (1:1)
10. Unii-7wnp51ka7m
11. Lsd D-(-)-tartrate
12. Lsd (d-tartrate) (solution)
13. Akos040752817
14. Ls-64353
15. Lysergic Acid Diethylamide D-tartrate
16. D-lysergic Acid Diethylamide D-tartrate
17. Q27268952
18. Ergoline-8-carboxamide, 9,10-didehydro-n,n-diethyl-6-methyl-, (8.beta.)-, (2s,3s)-2,3-dihydroxybutanedioate (1:1)
19. Ergoline-8-carboxamide, 9,10-didehydro-n,n-diethyl-6-methyl-, (8.beta.)-, (s-(r*,r*))-2,3-dihydroxybutanedioate (1:1)
20. Ergoline-8.beta.-carboxamide, 9,10-didehydro-n,n-diethyl-6-methyl-, (-)-tartrate (1:1)
| Molecular Weight | 473.5 g/mol |
|---|---|
| Molecular Formula | C24H31N3O7 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 6 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 154 |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 661 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
92
PharmaCompass offers a list of Lysergide D-tartrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lysergide D-tartrate manufacturer or Lysergide D-tartrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lysergide D-tartrate manufacturer or Lysergide D-tartrate supplier.
PharmaCompass also assists you with knowing the Lysergide D-tartrate API Price utilized in the formulation of products. Lysergide D-tartrate API Price is not always fixed or binding as the Lysergide D-tartrate Price is obtained through a variety of data sources. The Lysergide D-tartrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A LYSERGIC ACID DIETHYLAMIDE D-TARTRATE manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of LYSERGIC ACID DIETHYLAMIDE D-TARTRATE, including repackagers and relabelers. The FDA regulates LYSERGIC ACID DIETHYLAMIDE D-TARTRATE manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. LYSERGIC ACID DIETHYLAMIDE D-TARTRATE API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A LYSERGIC ACID DIETHYLAMIDE D-TARTRATE supplier is an individual or a company that provides LYSERGIC ACID DIETHYLAMIDE D-TARTRATE active pharmaceutical ingredient (API) or LYSERGIC ACID DIETHYLAMIDE D-TARTRATE finished formulations upon request. The LYSERGIC ACID DIETHYLAMIDE D-TARTRATE suppliers may include LYSERGIC ACID DIETHYLAMIDE D-TARTRATE API manufacturers, exporters, distributors and traders.
LYSERGIC ACID DIETHYLAMIDE D-TARTRATE Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of LYSERGIC ACID DIETHYLAMIDE D-TARTRATE GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right LYSERGIC ACID DIETHYLAMIDE D-TARTRATE GMP manufacturer or LYSERGIC ACID DIETHYLAMIDE D-TARTRATE GMP API supplier for your needs.
A LYSERGIC ACID DIETHYLAMIDE D-TARTRATE CoA (Certificate of Analysis) is a formal document that attests to LYSERGIC ACID DIETHYLAMIDE D-TARTRATE's compliance with LYSERGIC ACID DIETHYLAMIDE D-TARTRATE specifications and serves as a tool for batch-level quality control.
LYSERGIC ACID DIETHYLAMIDE D-TARTRATE CoA mostly includes findings from lab analyses of a specific batch. For each LYSERGIC ACID DIETHYLAMIDE D-TARTRATE CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
LYSERGIC ACID DIETHYLAMIDE D-TARTRATE may be tested according to a variety of international standards, such as European Pharmacopoeia (LYSERGIC ACID DIETHYLAMIDE D-TARTRATE EP), LYSERGIC ACID DIETHYLAMIDE D-TARTRATE JP (Japanese Pharmacopeia) and the US Pharmacopoeia (LYSERGIC ACID DIETHYLAMIDE D-TARTRATE USP).
